药物随机对照试验资格标准的概括性对于渐进性肺纤维化
Yet H Khor1,2,3,4, Kerri A Johannson5, Veronica Marcoux6
1Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, Australia yet.khor@monash.edu.
The European respiratory journal
|November 7, 2024
概括
对渐进性肺纤维化 (PPF) 的临床试验资格标准缺乏代表性,影响了患者的选择. 符合试验条件的患者表现出更快的强迫生命能力下降,但更好的生存率,因间歇性肺病亚型而异.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 药理疗的发现 药理疗的发现
背景情况:
- 渐进性肺纤维化 (PPF) 是新药开发的一个关键目标.
- 了解临床试验资格标准对于推进PPF药物治疗至关重要.
- 目前关于PPF试验资格及其对患者群体的影响的知识有限.
研究的目的:
- 评估PPF随机对照试验 (RCT) 中使用的资格标准.
- 评估这些标准在现实世界注册病人的代表性.
- 分析基于试验资格的强迫生命能力 (FVC) 变化和死亡率.
主要方法:
- 系统地搜索已完成和正在进行的PPF 2/3期RCT.
- 在PPFRCT的≥60%中使用的共同资格标准的识别.
- 将试验和指南定义的PPF标准应用于加拿大注册表队列.
- 分析标准的频率和与登记病人的健康结果的关联.
主要成果:
- 16个RCT使用了10个不同的PPF定义.
- 50%的试验定义的PPF患者和44%的指南定义的PPF患者满足了共同的试验标准.
- 符合试验条件的患者表现出更快的1年FVC下降,但改善了无移植生存率.
- 不能分类的ILD患者比CTD-ILD或HP-ILD患者更频繁地被排除在外.
- 在试验合格组内,FVC下降和生存率在ILD亚型之间有所不同.
结论:
- PPF RCT 使用不同的定义和标准,具有有限的代表性.
- 强迫性生命能力下降和无移植生存率根据试验资格而有所不同.
- 间歇性肺病亚型影响了符合条件的PPF患者的结果.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
235
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
235
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
153
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
153
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
01:11Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
01:25Pulmonary Function Tests
311
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
311